RGEN (STOCKS)
Repligen Corp
$129.063300
+6.473300 (+5.28%)
Prev close: $122.590000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Olivier Dominique Loeillot
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $7,381.06M
- Employees
- 1,778
- P/E (TTM)
- 141.82
- P/B (TTM)
- 3.28
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
16
Buy
5
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.49 | $0.45 | +0.0415 | +9.25% |
|
Sep 2025 (Q3)
|
$0.46 | $0.43 | +0.0332 | +7.78% |
|
Jun 2025 (Q2)
|
$0.37 | $0.40 | -0.0271 | -6.82% |
|
Mar 2025 (Q1)
|
$0.39 | $0.35 | +0.0378 | +10.73% |
Financial Statements
| Revenues | $738.26M |
| Benefits Costs and Expenses | $675.87M |
| Cost Of Revenue | $352.01M |
| Costs And Expenses | $683.09M |
| Gross Profit | $386.25M |
| Nonoperating Income/Loss | $7.22M |
| Operating Expenses | $331.08M |
| Selling, General, and Administrative Expenses | $290.51M |
| Depreciation and Amortization | $78.75M |
| Research and Development | $54.18M |
| Operating Income/Loss | $55.17M |
| Income/Loss From Continuing Operations After Tax | $48.89M |
| Income/Loss From Continuing Operations Before Tax | $62.38M |
| Income Tax Expense/Benefit | $13.49M |
| Income Tax Expense/Benefit, Current | $16.86M |
| Income Tax Expense/Benefit, Deferred | -$3.37M |
| Net Income/Loss | $48.89M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $48.89M |
| Net Income/Loss Available To Common Stockholders, Basic | $48.89M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.87 |
| Diluted Earnings Per Share | $0.86 |
| Basic Average Shares | 56,234 |
| Diluted Average Shares | 56,561 |
| Assets | $2.95B |
| Current Assets | $1.14B |
| Inventory | $170.46M |
| Other Current Assets | $966.93M |
| Noncurrent Assets | $1.81B |
| Fixed Assets | $186.61M |
| Intangible Assets | $386.15M |
| Other Non-current Assets | $1.24B |
| Liabilities | $843.57M |
| Current Liabilities | $135.83M |
| Accounts Payable | $30.01M |
| Wages | $40.14M |
| Other Current Liabilities | $65.68M |
| Noncurrent Liabilities | $707.74M |
| Long-term Debt | $542.21M |
| Other Non-current Liabilities | $165.53M |
| Equity | $2.11B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.11B |
| Liabilities And Equity | $2.95B |
| Net Cash Flow From Operating Activities | $117.42M |
| Net Cash Flow From Operating Activities, Continuing | $117.42M |
| Net Cash Flow From Investing Activities | -$298.47M |
| Net Cash Flow From Investing Activities, Continuing | -$298.47M |
| Net Cash Flow From Financing Activities | -$15.21M |
| Net Cash Flow From Financing Activities, Continuing | -$15.21M |
| Net Cash Flow | -$196.26M |
| Net Cash Flow, Continuing | -$196.26M |
| Comprehensive Income/Loss | $98.90M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $98.90M |
| Other Comprehensive Income/Loss | $50.00M |